Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Trending Product / SARS-CoV-2

Recombinant SARS-CoV-2 NSP9 Protein, N-His

Catalog #:   YVV01501 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: P0DTD1
Protein length: Asn4141-Gln4253
Overview

Catalog No.

YVV01501

Expression system

E. coli

Species

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Protein length

Asn4141-Gln4253

Predicted molecular weight

14.67 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

P0DTD1

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Non-structural protein 9, nsp9, Replicase polyprotein 1ab, pp1ab, ORF1ab polyprotein

Data Image
  • SDS-PAGE
    SDS PAGE for recombinant SARS-CoV-2 NSP9
References

Defining short linear motif binding determinants by phage display-based deep mutational scanning., PMID:40411416

Virtual Screening of Phytoconstituents in Indian Spices Based on their Inhibitory Potential against SARS-CoV-2., PMID:40353411

Peptide nucleic acids can form hairpins and bind RNA-binding proteins., PMID:39283902

Nanobody against SARS-CoV-2 non-structural protein Nsp9 inhibits viral replication in human airway epithelia., PMID:39281707

Mapping the immunopeptidome of seven SARS-CoV-2 antigens across common HLA haplotypes., PMID:39214998

Comparative Atlas of SARS-CoV-2 Substitution Mutations: A Focus on Iranian Strains Amidst Global Trends., PMID:39205305

One pot multi-component synthesis of novel functionalized pyrazolo furan-2(5H)-one derivatives: in vitro, DFT, molecular docking, and pharmacophore studies, as coronavirus inhibitors., PMID:39168959

A Biochemical and Biophysical Analysis of the Interaction of nsp9 with nsp12 from SARS-CoV-2-Implications for Future Drug Discovery Efforts., PMID:38958516

Investigating SARS-CoV-2 virus-host interactions and mRNA expression: Insights using three models of D. melanogaster., PMID:38925484

SARS-CoV-2 Protein Nsp9 Is Involved in Viral Evasion through Interactions with Innate Immune Pathways., PMID:38911767

Inhibition of SARS-CoV-2 Nsp9 ssDNA-Binding Activity and Cytotoxic Effects on H838, H1975, and A549 Human Non-Small Cell Lung Cancer Cells: Exploring the Potential of Nepenthes miranda Leaf Extract for Pulmonary Disease Treatment., PMID:38892307

Mutations in nonstructural proteins essential for pathogenicity in SARS-CoV-2-infected mice., PMID:38888344

Mutation prediction in the SARS-CoV-2 genome using attention-based neural machine translation., PMID:38872567

Genomic Context of SARS-CoV-2 Outbreaks in Farmed Mink in Spain during Pandemic: Unveiling Host Adaptation Mechanisms., PMID:38791536

Assessing nanobody interaction with SARS-CoV-2 Nsp9., PMID:38758765

Adaptation of SARS-CoV-2 to ACE2H353K mice reveals new spike residues that drive mouse infection., PMID:38168680

Discovery of Anti-SARS-CoV-2 Nsp9 Binders from Natural Products by a Native Mass Spectrometry Approach., PMID:37993134

A structural analysis of the nsp9 protein from the coronavirus MERS CoV reveals a conserved RNA binding interface., PMID:37929701

SARS-COV-2 protein NSP9 promotes cytokine production by targeting TBK1., PMID:37854611

SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9., PMID:37794589

Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets., PMID:37704626

Conserved Characteristics of NMPylation Activities of Alpha- and Betacoronavirus NiRAN Domains., PMID:37199624

Collision-Induced Affinity Selection Mass Spectrometry for Identification of Ligands., PMID:37101899

SARS-CoV-2 polyprotein substrate regulates the stepwise Mpro cleavage reaction., PMID:37044215

Inside-out: Antibody-binding reveals potential folding hinge-points within the SARS-CoV-2 replication co-factor nsp9., PMID:37036856

Global landscape of SARS-CoV-2 mutations and conserved regions., PMID:36841805

Genomic landscape of alpha-variant of SARS-CoV-2 circulated in Pakistan., PMID:36512569

Virtual screening of phytochemicals by targeting multiple proteins of severe acute respiratory syndrome coronavirus 2: Molecular docking and molecular dynamics simulation studies., PMID:36442514

Determination of binding affinity of tunicamycin with SARS-CoV-2 proteins: Proteinase, protease, nsp2, nsp9, ORF3a, ORF7a, ORF8, ORF9b, envelope and RBD of spike glycoprotein., PMID:36349218

A mechanism for SARS-CoV-2 RNA capping and its inhibition by nucleotide analog inhibitors., PMID:36335936

SARS-CoV-2 mitochondriopathy in COVID-19 pneumonia exacerbates hypoxemia., PMID:36334378

Structural modeling of protein ensembles between E3 RING ligases and SARS-CoV-2: The role of zinc binding domains., PMID:36209710

The mechanism of RNA capping by SARS-CoV-2., PMID:35944563

Affinity selection-mass spectrometry in the discovery of anti-SARS-CoV-2 compounds., PMID:35929396

Expression Profile and Localization of SARS-CoV-2 Nonstructural Replicase Proteins in Infected Cells., PMID:35730969

SARS-CoV-2 couples evasion of inflammatory response to activated nucleotide synthesis., PMID:35700355

Discovery and functional interrogation of SARS-CoV-2 protein-RNA interactions., PMID:35313591

Discovery and functional interrogation of SARS-CoV-2 protein-RNA interactions., PMID:35233578

Collection of Monoclonal Antibodies Targeting SARS-CoV-2 Proteins., PMID:35216036

The mechanism of RNA capping by SARS-CoV-2., PMID:35194601

Shedding Light on the Synthesis, Crystal Structure, Characterization, and Computational Study of Optoelectronic Properties and Bioactivity of Imine derivatives., PMID:35187337

Anti-SARS-CoV-2 IgG responses are powerful predicting signatures for the outcome of COVID-19 patients., PMID:35116173

NSP9 of SARS-CoV-2 attenuates nuclear transport by hampering nucleoporin 62 dynamics and functions in host cells., PMID:34844119

Structural, energetic and lipophilic analysis of SARS-CoV-2 non-structural protein 9 (NSP9)., PMID:34837010

A natural product compound inhibits coronaviral replication in vitro by binding to the conserved Nsp9 SARS-CoV-2 protein., PMID:34756886

NMR-Based Analysis of Nanobodies to SARS-CoV-2 Nsp9 Reveals a Possible Antiviral Strategy Against COVID-19., PMID:34705339

Polypharmacology of some medicinal plant metabolites against SARS-CoV-2 and host targets: Molecular dynamics evaluation of NSP9 RNA binding protein., PMID:34370622

A distinct ssDNA/RNA binding interface in the Nsp9 protein from SARS-CoV-2., PMID:34369011

NMPylation and de-NMPylation of SARS-CoV-2 nsp9 by the NiRAN domain., PMID:34352100

Binding of a pyrimidine RNA base-mimic to SARS-CoV-2 nonstructural protein 9., PMID:34331944

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant SARS-CoV-2 NSP9 Protein, N-His [YVV01501]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only